Table of Contents Author Guidelines Submit a Manuscript
Stroke Research and Treatment
Volume 2017 (2017), Article ID 8593207, 12 pages
https://doi.org/10.1155/2017/8593207
Review Article

Epidemiology and Management of Atrial Fibrillation and Stroke: Review of Data from Four European Countries

1eMbrace Institute, Amsterdam, Netherlands
2Institute of Health Policy & Management, Erasmus University Rotterdam, Postbus 1738, 3000 DR Rotterdam, Netherlands
3Institute for Medical Technology Assessment, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, Netherlands

Correspondence should be addressed to Andreea D. Ceornodolea; ln.rue.gmb@aelodonroec

Received 19 December 2016; Revised 13 March 2017; Accepted 20 April 2017; Published 28 May 2017

Academic Editor: David Vaudry

Copyright © 2017 Andreea D. Ceornodolea et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Camm, P. Kirchhof, Y. H. G. Lip et al., “Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European society of cardiology (ESC),” Eur Heart J, vol. 31, no. 19, pp. 2369–2429, 2010. View at Google Scholar
  2. P. Kirchhof, B. Ammentorp, H. Darius et al., “Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention of thromboemolic events-European registry in atrial fibrillation (PREFER in AF),” Europace, vol. 16, no. 1, pp. 6–14, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. I. M. Ogilvie, N. Newton, S. A. Welner, W. Cowell, and G. Y. H. Lip, “Underuse of oral anticoagulants in atrial fibrillation: a systematic review,” The American Journal of Medicine, vol. 123, no. 7, pp. 637–645, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Marini, F. De Santis, S. Sacco et al., “Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study,” Stroke, vol. 36, no. 6, pp. 1115–1119, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Kakar, C. J. Boss, and G. Y. H. Lip, “Management of atrial fibrillation,” Vasc Health Risk Manag, vol. 3, no. 1, pp. 109–116, 2007. View at Google Scholar
  6. P. A. Wolf, R. D. Abbott, and W. B. Kannel, “Atrial fibrillation as an independent risk factor for stroke: the framingham study,” Stroke, vol. 22, no. 8, pp. 983–988, 1991. View at Publisher · View at Google Scholar · View at Scopus
  7. B. P. Krijthe, A. Kunst, E. J. Benjamin et al., “Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060,” European Heart Journal, vol. 34, no. 35, pp. 2746–2751, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Kirchhof, G. Breithardt, J. Bax et al., “A roadmap to improve the quality of atrial fibrillation management,” in Proceedings from the Fifth Atrial Fibrillation Network/European Heart Rhythm Association Consensus Conference, 2015. View at Publisher · View at Google Scholar
  9. G. Y. H. Lip, C. Laroche, M. I. Popescu et al., “Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF general pilot Registry,” Europace, vol. 17, no. 12, pp. 1777–1786, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. A. R. Kaba, J. A. Camm, M. T. Williams, and R. Sharma, “Managing atrial fibrillation in the global community: the European Perspective,” Glob Carrdiol Sci Pract, vol. 24, no. 2, pp. 173–184, 2013. View at Publisher · View at Google Scholar
  11. G. Y. H. Lip, A. K. Gitt, J.-Y. Le Heuzey et al., “Overtreatment and undertreatment with anticoagulation in relation to cardioversion of atrial fibrillation (the rhythm-af study),” American Journal of Cardiology, vol. 113, no. 3, pp. 480–484, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Nieuwlaat, A. Capucci, A. J. Camm, S. B. Olsson, D. Andresen, Y. J. Le Heuzey et al., “Atrial fibrillation management: a prospective survey in ESC member countries the euro heart survey on atrial fibrillation,” Eur Heart J, vol. 26, pp. 2422–2234, 2005. View at Publisher · View at Google Scholar
  13. H. E. Heemstra, R. Nieuwlaat, M. Meijboom, and H. J. Crijns, “The burden of atrial fibrillation in the Netherlands,” Netherlands Heart Journal, vol. 19, no. 9, pp. 373–378, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. T. N. Nguyen, S. N. Hilmer, and R. G. Cumming, “Review of epidemiology and management of atrial fibrillation in developing countries,” International Journal of Cardiology, vol. 167, no. 6, pp. 2412–2420, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Malmivaara, A. Meretoja, M. Peltola et al., “Comparing ischaemic stroke in six European countries. The EuroHOPE register study,” European Journal of Neurology, vol. 22, no. 2, pp. 284–291, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Fuster, L. E. Ryden, D. S. Cannom et al., “ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the american college of cardiology/american heart association task force on practice guidelines and the european society of cardiology committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society,” Circulation, vol. 114, pp. e257–e354, 2006. View at Publisher · View at Google Scholar
  17. J. Perk, G. De Backer, H. Gohlke et al., “The fifth joint task force of the european society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) developed with the special contribution of the European Association for cardiovascular prevention & amp,” in Eur Heart J, vol. 33, p. 2126, 2012. View at Publisher · View at Google Scholar
  18. G. Y. H. Lip, C. M. Brechin, and D. A. Lane, “The global burden of atrial fibrillation and stroke: A systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe,” Chest, vol. 142, no. 6, pp. 1489–1498, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Zhang, A.-M. Chapman, M. Plested, D. Jackson, and F. Purroy, “The incidence, prevalence, and mortality of stroke in France, Germany, Italy, Spain, the UK, and the US: A literature review,” Stroke Research and Treatment, Article ID 436125, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Truelsen, B. Piechowski-Jóźwiak, R. Bonita, C. Mathers, J. Bogousslavsky, and G. Boysen, “Stroke incidence and prevalence in Europe: a review of available data,” European Journal of Neurology, vol. 13, no. 6, pp. 581–598, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Fumagalli, R. Nieuwlaat, F. Tarantini et al., “management and prognosis of elderly patients in the Euro Heart Survey on atrial fibrillation,” Aging Clin Exp Res, vol. 24, no. 5, pp. 517–523, 2012. View at Publisher · View at Google Scholar
  22. G. Y. H. Lip, C. Laroche, G. Boriani et al., “Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational research programme atrial fibrillation (EORP-AF) pilot General Registry,” Europace, vol. 17, no. 2, pp. 194–206, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Grosios, P. B. Gahan, and J. Burbidge, “Overview of healthcare in the UK,” EPMA Journal, vol. 1, no. 4, pp. 529–534, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Chevreul, I. Durand-Zaleski, S. Bahrami, C. Hernandez-Quevedo, and P. F. Mladovsky, “Health system review,” Health Syst Transit, vol. 12, no. 6, pp. 1–291, 2010. View at Google Scholar
  25. S. Sandier, V. Paris, and D. Polton, “HiT summary France,” Health Syst Transit, pp. 1–9, 2004. View at Google Scholar
  26. S. Thomson, R. Osborn, D. Squires, and M. Jun, “International profiles of health care systems, 2013 Australia, Canada, Denmark, England, France, Germany, Italy, Japan, the Netherlands, New Zealand, Norway, Sweden, Switzerland, and the United States,” Commonwealth Fund, no. 1717, pp. 37–44, 2013. View at Google Scholar
  27. W. Schafer, M. Kroneman, W. Boerma et al., “Health system review. World Health Organization 2009, on behalf of the European Observatory on health systems and policies,” vol. 12, no. 1, pp. 1–267, 2010. View at Google Scholar
  28. OECD, “ealth at a glance,” http://dx.doi.org/10.1787/health_glance_eur-2014-en.
  29. R. C. Davis, F. D. R. Hobbs, J. E. Kenkre et al., “Prevalence of atrial fibrillation in the general population and in high-risk groups: The ECHOES study,” Europace, vol. 14, no. 11, pp. 1553–1559, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Charlemagne, J. Blacher, A. Cohen et al., “Epidemiology of atrial fibrillation in France: Extrapolation of international epidemiological data to France and analysis of French hospitalization data,” Archives of Cardiovascular Diseases, vol. 104, no. 2, pp. 115–124, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Barra and S. Fynn, “Untreated atrial fibrillation in the United Kingdom: understanding the barriers and treatment options,” Journal of the Saudi Heart Association, vol. 27, no. 1, pp. 31–43, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. F.-E. Cotté, G. Chaize, I. Kachaner, A.-F. Gaudin, A. Vainchtock, and I. Durand-Zaleski, “Incidence and cost of stroke and hemorrhage in patients diagnosed with atrial fibrillation in France,” Journal of Stroke and Cerebrovascular Diseases, vol. 23, no. 2, pp. e73–e83, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. OECD, “Mortality from Heart Disease and Stroke,” http://dx.doi.org/10.1787/health_glance-2011-6-en.
  34. NICE Clinical Guideline 180, “Atrial fibrillation: the management of atrial fibrillation NICE 2014,” www.guidance.nice.org.uk/cg180.
  35. NICE, “Atrial fibrillation: medicines to help reduce risk of stroke – what are the options? NICE 2014,” http://guidance.nice.org.uk/CG180/PatientDecisionAid/pdf/ English.
  36. S. Lévy, M. Maarek, P. Coumel et al., “Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study,” Circulation, vol. 99, no. 23, pp. 3028–3035, 1999. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Touzé, J.-P. Cambou, J. Ferrières et al., “Antithrombotic management after an ischemic stroke in French primary care practice: results from three pooled cross-sectional studies,” Cerebrovascular Diseases, vol. 20, no. 2, pp. 78–84, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Purcarea and C. Usurelu, “Terapia antitrombotica revista societatii de medicina interna,” vol. 1, 2009. View at Google Scholar
  39. F. R. Rosendaal, F. J. M. Van der Meer, and S. C. Cannegieter, “Management of anticoagulant therapy: the Dutch experience,” J Thromb Thrombolysis, vol. 2, no. 4, pp. 265–269, 1996. View at Google Scholar
  40. Federatie van Nederlandse Trombosediensten, http://www.fnt.nl/algemeen/jaarverslagen.html.
  41. R. Willemsen, R. Pisters, H. Crijns, and B. de Wit, “Implementatie van antitrombotische behandeling bij atriumfibrilleren,” Huisarts En Wetenschap, vol. 54, no. 4, pp. 192–196, 2011. View at Publisher · View at Google Scholar
  42. J.-Y. Le Heuzey, B. Ammentorp, H. Darius et al., “Differences among western European countries in anticoagulation management of atrial fibrillation: data from the PREFER IN AF Registry,” Thrombosis and Haemostasis, vol. 111, no. 5, pp. 833–841, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. D. L. Arts, S. Visscher, W. Opstelten, J. C. Korevaar, A. Abu-Hanna, and H. C. P. M. van Weert, “Frequency and risk factors for under- and over-treatment in stroke prevention for patients with non-valvular atrial fibrillation in general practice,” PLoS ONE, vol. 8, no. 7, Article ID e67806, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Zdrenghea, D. Pop, O. Penciu, and M. Zdrenghea, “Drug Treatment of Heart Failure in a General Romanian Hospital,” Ro J internal med, vol. 47, no. 3, pp. 227–233, 2009. View at Google Scholar
  45. E. Shantsila, A. Wolff, G. Y. H. Lip, and D. A. Lane, “Optimising stroke prevention in patients with atrial fibrillation: application of the grasp-af audit tool in a uk general practice cohort,” British Journal of General Practice, vol. 65, no. 630, pp. e16–e23, 2015. View at Publisher · View at Google Scholar · View at Scopus
  46. S. DeWilde, I. M. Carey, C. Emmas, N. Richards, and D. G. Cook, “Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care,” Heart, vol. 92, no. 8, pp. 1064–1070, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. F. D. R. Hobbs, D. A. Fitzmaurice, and S. Jowett, “The SAFE study-full report,” Health Technol Assess 40, 2005. View at Google Scholar
  48. NICE, “Atrial Fibrillation: the management of atrial fibrillation costing report implementing NICE Guidance in England.,” www.nice.org.uk/guidance/cg36.
  49. D. A. Fitzmaurice, F. D. R. Hobbs, S. Jowett et al., “Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial,” British Medical Journal, vol. 335, no. 7616, pp. 383–386, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. G. V. Naccarelli, H. Varker, J. Lin, and K. L. Schulman, “Increasing prevalence of atrial fibrillation and flutter in the United States,” American Journal of Cardiology, vol. 104, no. 11, pp. 1534–1539, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Wilke, A. Groth, S. Mueller et al., “Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients,” Europace, vol. 15, no. 4, pp. 486–493, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Vladescu, G. Scîntee, V. Olsavszky, S. Allin, and P. Mladovsky, “Health system review,” Health Syst Transit, vol. 10, no. 3, pp. 1–172, 2008. View at Google Scholar
  53. D. L. Arts, A. G. Voncken, S. Medlock, A. Abu-Hanna, and H. C. P. M. van Weert, “Reasons for intentional guideline non-adherence: A systematic review,” International Journal of Medical Informatics, vol. 89, pp. 55–62, 2016. View at Publisher · View at Google Scholar · View at Scopus